Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis

被引:7
作者
Francois, Mercier [1 ]
Peter, Chin [2 ]
Gordon, Francis [2 ]
机构
[1] Pharsight Consulting Serv, St Louis, MO USA
[2] Novartis Pharmaceut, Neuroinflammat Clin Sci Unit, E Hanover, NJ USA
关键词
negative binomial; zero inflation; count; brain lesion; generalized linear mixed-effect model; multiple sclerosis; fingolimod; INFLATED POISSON REGRESSION; NEGATIVE BINOMIAL MODEL; CLINICAL-TRIALS; GADOLINIUM-ENHANCEMENT; HURDLE MODELS; SCORE TESTS; FINGOLIMOD; DISABILITY; LIKELIHOOD;
D O I
10.1002/pst.1529
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lesion count observed on brain magnetic resonance imaging scan is a common end point in phase?2 clinical trials evaluating therapeutic treatment in relapsing remitting multiple sclerosis (MS). This paper compares the performances of Poisson, zero-inflated poisson (ZIP), negative binomial (NB), and zero-inflated NB (ZINB) mixed-effects regression models in fitting lesion count data in a clinical trial evaluating the efficacy and safety of fingolimod in comparison with placebo, in MS. The NB and ZINB models prove to be superior to the Poisson and ZIP models. We discuss the advantages and limitations of zero-inflated models in the context of MS treatment. Copyright (C) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:417 / 424
页数:8
相关论文
共 43 条
  • [1] A longitudinal model for magnetic resonance imaging lesion count data in multiple sclerosis patients
    Altman, Rachel MacKay
    Petkau, A. John
    Vrecko, Dean
    Smith, Alex
    [J]. STATISTICS IN MEDICINE, 2012, 31 (05) : 449 - 469
  • [2] [Anonymous], 2002, Model selection and multimodel inference: a practical informationtheoretic approach
  • [3] [Anonymous], 2011, NEGATIVE BINOMIAL RE
  • [4] [Anonymous], 1994, 9410 NEW YORK U LN S
  • [5] Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials
    Barkhof, F
    Held, U
    Simon, JH
    Daumer, M
    Fazekas, F
    Filippi, M
    Frank, JA
    Kappos, L
    Li, D
    Menzler, S
    Miller, DH
    Petkau, J
    Wolinsky, J
    [J]. NEUROLOGY, 2005, 65 (09) : 1447 - 1454
  • [6] The Use of MR Imaging as an Outcome Measure in Multiple Sclerosis Clinical Trials
    Bermel, Robert A.
    Fisher, Elizabeth
    Cohen, Jeffrey A.
    [J]. NEUROIMAGING CLINICS OF NORTH AMERICA, 2008, 18 (04) : 687 - 701
  • [7] Zero-inflated models for regression analysis of count data: a study of growth and development
    Bin Cheung, Y
    [J]. STATISTICS IN MEDICINE, 2002, 21 (10) : 1461 - 1469
  • [8] Negative binomial loglinear mixed models
    Booth, JG
    Casella, G
    Friedl, H
    Hobert, JP
    [J]. STATISTICAL MODELLING, 2003, 3 (03) : 179 - 191
  • [9] FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
    Brinkmann, Volker
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (05) : 1173 - 1182
  • [10] Cook R.J., 2010, The Statistical Analysis of Recurrent Events (Statistics for Biology and Health)